{
  "trial_id": "NCT04439955",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "active CSU for at least 4 months",
      "label": "met",
      "evidence": "positive anti-AChR antibody test"
    },
    {
      "criterion": "at least one course of steroids",
      "label": "met",
      "evidence": "pyridostigmine 60 mg three times a day"
    },
    {
      "criterion": "Age \u226518 years",
      "label": "met",
      "evidence": "35-year-old woman"
    },
    {
      "criterion": "ECG and QT parameters will be measured for further analysis",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Female subjects who are postmenopausal or surgically sterilized",
      "label": "met",
      "evidence": "absence of menses for \u2265 2 years confirmed by a follicle stimulating hormone test"
    },
    {
      "criterion": "Women of childbearing potential with negative pregnancy test and willing to use contraception",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Female subjects who are not breast-feeding",
      "label": "met",
      "evidence": "no intention to breast-feed during the term of the trial"
    },
    {
      "criterion": "Subject able to provide written informed consent",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Viral Hepatitis (HAV, HBV, HCV)",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Serious psychiatric or psychological disorders",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Other chronic dermatological conditions under active treatment",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Active consumption of illicit drugs including cannabis or derivatives for at least three months prior to the study",
      "label": "met",
      "evidence": "does not smoke or use illicit drugs"
    },
    {
      "criterion": "Patients with significant cardiac, respiratory or active malignance disease (except Basel Cell Carcinoma) comorbidities",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Any uncontrolled infection at time of registration",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Renal comorbidity: eGFR < 30 mL/min/1.73m2",
      "label": "not_met",
      "evidence": "Creatinine: 0.5 mg/dl"
    },
    {
      "criterion": "Patient who is taking immunomodulatory medications for other indication",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Women of child-bearing potential who intend to become pregnant or who are pregnant or breastfeeding",
      "label": "met",
      "evidence": "negative for pregnancy"
    }
  ],
  "notes": "35-year-old woman with myasthenia gravis, class IIa. She complains of diplopia and fatigue and weakness that affects mainly her upper limbs.",
  "_meta": {
    "topic_id": "38",
    "trial_id": "NCT04439955",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}